💨 Where the Rumors Started
Talk of Ayr’s exit gained traction after Connecticut Cannabis Ombudsman Erin Gorman Kirk mentioned in a podcast and CT News Junkie interview that Ayr was reportedly considering selling its sole Connecticut license—a move mirroring Acreage Holdings’ recent retreat from the state.
🚀 What Ayr Is Saying
Rob Vanisko, spokesperson for the Florida-based company, emphasized that Ayr’s Manchester dispensary—run in partnership with a social-equity license holder—continues to operate as usual.
🌍 A Strategy in Context
This Connecticut episode comes during a broader period of consolidation for Ayr. The company is reportedly offloading Illinois stores amid a mounting debt burden—losing $133 million in Q4 2024—and eyeing a potential $358 million in loans maturing by 2026. With a heavy focus on key markets—Florida, Massachusetts, New Jersey, Nevada, Ohio, and Pennsylvania—Connecticut ranks low in the company’s strategic roster.
⚖️ Regulatory & Social Equity Angle
Connecticut’s highly regulated and vertically integrated cannabis system poses significant barriers to entry. Strict licensing fees—including a $3 million cultivation fee—and tight rules around product naming and licensing have made the state a tough market, especially for out-of-state MSOs. Exiting Connecticut could have ripple effects for Ayr’s social equity partner, Tiana Hercules, a former Hartford councilwoman whose business interests are tied to the dispensary.
🧭 Final Take
For now, Ayr appears committed to staying—at least publicly. But with debt maturities looming and a sharpened focus on core states, its long-term strategy for Connecticut remains unclear. Those watching the market should keep an eye on how regulatory complexity and financial pressures continue to shape MSO decisions in smaller jurisdictions.
Dabbin-Dad Newsroom
If you liked this post, say thanks by sharing it
